Detalhe da pesquisa
1.
A comparative assessment of clinical, pharmacological and antimicrobial profile of novel anti-methicillin-resistant Staphylococcus aureus agent levonadifloxacin: Therapeutic role in nosocomial and community infections.
Indian J Med Microbiol
; 37(4): 478-487, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-32436868